BMS-777607, a potent small molecule c-MET inhibitor, inhibits prostate cancer progression in vitro

被引：1
|
作者：
Dai, Yao
Siemann, Dietmar
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0190
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts
    Puri, Neelu
    Khramtsov, Andrey
    Ahmed, Salman
    Nallasura, Vidya
    Hetzel, Jeremy T.
    Jagadeeswaran, Ramasamy
    Karczmar, Greg
    Salgia, Ravi
    CANCER RESEARCH, 2007, 67 (08) : 3529 - 3534
  • [22] A c-met inhibitor in the treatment of metastatic non small cell lung cancer with c-met amplification.
    Zhang, Tongtong
    Li, Junling
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] SGX126: a novel, potent and highly selective small molecule inhibitor of the c-Met receptor tyrosine kinase
    Buchanan, S.
    Jessen, K.
    Tang, C.
    Sperry, S.
    Smith, C.
    Bounaud, R.
    Hendle, J.
    Lee, P.
    Gessert, S.
    Reich, S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 177 - 177
  • [24] A selective small-molecule inhibitor of c-Met suppresses keloid fibroblast growth in vitro and in a mouse model
    Choi, Min-Ha
    Kim, Jinhyun
    Ha, Jeong Hyun
    Park, Ji-Ung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [25] A selective small-molecule inhibitor of c-Met suppresses keloid fibroblast growth in vitro and in a mouse model
    Min-Ha Choi
    Jinhyun Kim
    Jeong Hyun Ha
    Ji-Ung Park
    Scientific Reports, 11
  • [26] c-Met antagonist Avimer™ polypeptide that exhibits potent in vivo and in vitro inhibitor activity
    Cho, Song
    Smith, Richard
    Duguay, Amy
    Li, Peng
    Bakker, Alice
    Alba, Ben
    Thomas, Melissa
    To, Wayne
    Silverman, Josh
    Swimmer, Candace
    Moore, Kevin
    Strout, Patrick
    Bobofchak, Kevin
    McCarthy, Mike
    Pemmaraju, Kalyani
    Lacourciere, Gerard
    Zhou, Qin
    Damschroder, Melissa
    Wu, Herren
    Coats, Steve
    Kamal, Adeela
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] Elucidating the role of c-Met overexpression and its regulation in prostate cancer progression
    Gaur, Sanchaika
    Gallick, Gary E.
    CANCER RESEARCH, 2011, 71
  • [28] A selective small molecule c-MET inhibitor, PHA665752, cooperates with rapamycin
    Ma, PC
    Schaefer, E
    Christensen, JG
    Salgia, R
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2312 - 2319
  • [29] A novel, potent, highly selective inhibitor of c-Met kinase, Simm559, inhibits c-Met-dependent neoplastic phenotypes in vitro and in vivo.
    Ai, Jing
    Zhan, ZhengSheng
    Wang, Ying
    Chen, Fang
    Peng, Xia
    Chen, Yi
    Ji, Yinchun
    Ding, Jian
    Geng, Meiyu
    Duan, Wenhu
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [30] Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer
    Sima, Lijie
    Wang, Zhongyuan
    Yu, Ling
    Hou, Youli
    Zhao, Dongsheng
    Luo, Bilan
    Liao, Weike
    Liu, Xinfu
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01) : 2286435
12345